Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director

Mon, 27th Apr 2020 13:52

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Corero Network Security PLC - defence against denial of service cyber attacks - Hires Lionel Chmilewsky as chief executive officer designate, starting on Friday. Chmilewsky will take over as CEO from Ashley Stephenson on July 1. Stephenson will move over to chief technology officer, remaining on the board. Chmilewsky was most recently CEO of Cambridge Broadband Networks Ltd. Corero also hires Neil Pritchard as finance director, from Friday. Pritchard was financial director at CML Microsystems PLC. Andrew Miller steps down as chief financial officer of Corero but remains as a non-executive director. CML had announced Pritchard's departure back in November, saying at the time he had resigned "to pursue other career opportunities". It later said Non-Executive Chair Nigel Clark would take on the additional role of finance director while it reviews its finance function.

----------

Carclo PLC - engineering - Promotes Non-Executive Director Joe Oatley to chair, effective immediately. Oatley is the former CEO of industrial services firm Cape PLC. He joined Carclo board in July 2018 and also is on the board of construction company Wates Group Ltd. Carclo said that since Mark Rollins left as chair on March 24, the Covid-19 crisis has delayed the search for a permanent replacement, so Oatley agreed to be chair until a longer-term replacement is found. "The board believes that it is essential to have a chairman in place given the current challenging market environment and the need to secure a long-term financing position for the group," Carclo said.

----------

Aston Martin Lagonda Global Holdings PLC - car maker - Michael de Picciotto joins board immediately as representative non-executive director of Yew Tree Consortium. De Picciotto is vice chair of supervisory board of Engel & Volkers AG. He has waived his board fee for 2020. Yew Tree is a company controlled by lead investor and new Aston Martin chair Lawrence Stroll.

----------

ECO Animal Health Group PLC - livestock vaccines - Hires Frank Armstrong as non-executive director. Armstrong already is non-executive chair of Faron Pharmaceutical Oy and Caldan Therapeutics Ltd.

----------

Tristel PLC - infection prevention - Hires Isabel Napper as non-executive director. Napper was a partner at law firm Mills & Reeve and currently is a non-executive director of SDI Group PLC.

----------

Vaalco Energy Inc - exploration and development in West Africa - William Thomas resigns as president and from board with immediate effect. His "resignation was not in connection with any disagreement with the company on any matter relating to the company's operations, policies or practices," it notes.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Mar 2020 10:26

Faron gets FDA tick from proposed design of next 'Traumakine' study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design for the next 'Traumakine' study in acute respiratory distress syndrome (ARDS) patients, following its protocol submission in February.

Read more
5 Mar 2020 14:28

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Read more
2 Mar 2020 12:04

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Read more
2 Mar 2020 10:08

Faron Pharmaceuticals acquires rights to AOC3 inhibitors

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has acquired rights for the potential new use of AOC3 inhibitors covered by a recently filed patent application.

Read more
6 Feb 2020 14:17

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Read more
27 Jan 2020 11:22

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Read more
13 Jan 2020 11:54

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Read more
30 Dec 2019 15:39

Faron Pharma requests arbitration over Traumakine manufacturing deal

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that, further to the update on 'Traumakine' drug substance manufacturing on 2 October, it has carried out a detailed investigation into the circumstances around manufacturing arrangements.

Read more
30 Dec 2019 10:56

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Read more
11 Dec 2019 13:42

Faron Pharmaceuticals upbeat on new data from 'MATINS' study

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced new data from 'MATINS'-trial patients on Wednesday, to be presented at the ESMO Immuno-Oncology Congress 2019 in Geneva.

Read more
11 Dec 2019 10:45

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Read more
29 Nov 2019 10:23

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Read more
28 Nov 2019 11:56

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Read more
21 Nov 2019 12:56

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Read more
8 Nov 2019 10:30

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.